005: Discovering therapeutic targets in CLL

HIPO Investigator:

Prof. Thorsten Zenz

Dr. Leopold Sellner


Supported by: HIPO/NCT-POP

Entity: CLL


Dietrich S et al. Drug-perturbation-based stratification of blood cancer. J Clin Invest. 2018

Wu B et al.; MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia; Br J Haematol. 2017

Dietrich S. et al.; BRAF inhibition in hairy cell leukemia with low-dose vemurafenib; Blood 2016

Dietrich S et al.; Recurrent CDKN1B (p27) mutations in hairy cell leukemia; Blood 2015  

Dietrich S et al.; Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia; J Clin Oncol 2013

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.